CHM Ann: Agreement with MD Anderson for Phase 1B CHM 0201 AML study - 13th Sep 2023, 8:18am

annb0t

annb0t

Top 20
CHM Ann: Agreement with MD Anderson for Phase 1B CHM 0201 AML study
Price Sensitive: Y
Date: 13th Sep 2023, 8:18am

>>> Read announcement: Google: CHM Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
CHM Ann: License agreement with CWRU - supplementary announcement - 24th Nov 2022, 9:45am
Replies
0
Views
118
annb0t
annb0t
annb0t
CHM Ann: Exclusive license agreement with CWRU for CORE-NK platform - 21st Nov 2022, 10:14am
Replies
0
Views
149
annb0t
annb0t
annb0t
CHM Ann: Sponsored Research Agreement to advance CORE-NK portfolio - 2nd Nov 2022, 9:32am
Replies
0
Views
135
annb0t
annb0t
annb0t
CHM Ann: A$30 million Equity Placement Agreement with L1 Capital - 9th Jun 2022, 10:23am
Replies
0
Views
294
annb0t
annb0t
annb0t
CHM Ann: Quarterly Activities/Appendix 4C Cash Flow Report - 31st Oct 2023, 10:25am
Replies
0
Views
105
annb0t
annb0t
Top Bottom